UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 472

Sortiert nach

Functional Gene Variants of CYP3A4

Clinical pharmacology and therapeutics, 2014-09, Vol.96 (3), p.340-348

2014

Link zum Volltext

Verfügbarkeit prüfen

Genetic and Epigenetic Mechanisms of Tki Resistance

Clinical therapeutics, 2017-08, Vol.39 (8), p.e102-e102

Cascorbi, I

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication

European journal of clinical investigation, 2003-11, Vol.33 (s2), p.17-22

Cascorbi, I.

2003

Link zum Volltext

Verfügbarkeit prüfen

ABC Transporters in Drug-Refractory Epilepsy: Limited Clinical Significance of Pharmacogenetics?

Clinical pharmacology and therapeutics, 2010-01, Vol.87 (1), p.15-18

Cascorbi, I

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Treatment of Pain: Future Trends and Novel Insights

Clinical pharmacology and therapeutics, 2015-02, Vol.97 (2), p.104-108

Cascorbi, I

2015

Link zum Volltext

Verfügbarkeit prüfen

Epigenetics in Drug Response

Clinical pharmacology and therapeutics, 2016-05, Vol.99 (5), p.468-470

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic basis of toxic reactions to drugs and chemicals

Toxicology letters, 2006-03, Vol.162 (1), p.16-28

Cascorbi, Ingolf

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomic or -epigenomic biomarkers in drug treatment: Two sides of the same medal?

Clinical pharmacology and therapeutics, 2016-05, Vol.99 (5), p.478-480

2016

Link zum Volltext

Verfügbarkeit prüfen

Progress in Pharmacogenomics: Bridging the Gap From Research to Practice

Clinical pharmacology and therapeutics, 2014-03, Vol.95 (3), p.231-235

2014

Link zum Volltext

Verfügbarkeit prüfen

Functional Polymorphisms of the Human Multidrug-Resistance Gene: Multiple Sequence Variations and Correlation of One Allele with P-Glycoprotein Expression and Activity in vivo

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (7), p.3473-3478

2000

Link zum Volltext

Verfügbarkeit prüfen

CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients

Clinical pharmacology and therapeutics, 2007-02, Vol.81 (2), p.228-234

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

The pharmacogenomics journal, 2011-02, Vol.11 (1), p.25-34

2011

Link zum Volltext

Verfügbarkeit prüfen

Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

Clinical pharmacology and therapeutics, 2001-03, Vol.69 (3), p.169-174

2001

Link zum Volltext

Verfügbarkeit prüfen

Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden

Molecular psychiatry, 2005-02, Vol.10 (2), p.220-224

2005

Link zum Volltext

Verfügbarkeit prüfen

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

The pharmacogenomics journal, 2007-02, Vol.7 (1), p.56-65

2007

Link zum Volltext

Verfügbarkeit prüfen

Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance

Clinical pharmacology and therapeutics, 2014-04, Vol.95 (4), p.416-422

2014

Link zum Volltext

Verfügbarkeit prüfen

A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006-01, Vol.830 (1), p.143-150

2006

Link zum Volltext

Verfügbarkeit prüfen

Elimination Half-Life of Anti-Müllerian Hormone

The journal of clinical endocrinology and metabolism, 2012-06, Vol.97 (6), p.2160-2163

2012

Link zum Volltext

Verfügbarkeit prüfen

P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations

Handbook of experimental pharmacology, 2011-01 (201), p.261

Cascorbi, Ingolf

2011

Link zum Volltext

Verfügbarkeit prüfen

A C4887A polymorphism in exon 7 of human CYP1A1 : Population frequency, mutation linkages, and impact on lung cancer susceptibility

Cancer research (Chicago, Ill.), 1996-11, Vol.56 (21), p.4965-4969

1996

Link zum Volltext

Verfügbarkeit prüfen

Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer

Cancer chemotherapy and pharmacology, 2015-01, Vol.75 (1), p.207-214

2015

Link zum Volltext

Verfügbarkeit prüfen

Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens

The pharmacogenomics journal, 2007-10, Vol.7 (5), p.325-332

2007

Link zum Volltext

Verfügbarkeit prüfen

PP123—Target gene evaluation of two mirnas differently expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients

Clinical therapeutics, 2013-08, Vol.35 (8), p.e53-e54

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of CYP3A4, CYP3A5, and ABCB1 Genotype and Expression on Budesonide Pharmacokinetics: A Possible Role of Intestinal CYP3A4 Expression

Clinical pharmacology and therapeutics, 2008-07, Vol.84 (1), p.43-46

2008

Link zum Volltext

Verfügbarkeit prüfen

Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19

The pharmacogenomics journal, 2005-12, Vol.5 (6), p.365-373

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 472

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(405)
Mit Volltextzugriff
(431)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(447)
Japanisch
(49)
Deutsch
(27)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Functional Gene Variants of CYP3A4

Genetic and Epigenetic Mechanisms of Tki Resistance

Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication

ABC Transporters in Drug-Refractory Epilepsy: Limited Clinical Significance of Pharmacogenetics?

Pharmacological Treatment of Pain: Future Trends and Novel Insights

Epigenetics in Drug Response

Genetic basis of toxic reactions to drugs and chemicals

Pharmacogenomic or -epigenomic biomarkers in drug treatment: Two sides of the same medal?

Progress in Pharmacogenomics: Bridging the Gap From Research to Practice

Functional Polymorphisms of the Human Multidrug-Resistance Gene: Multiple Sequence Variations and Correlation of One Allele with P-Glycoprotein Expression and Activity in vivo

CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance

A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1

Elimination Half-Life of Anti-Müllerian Hormone

P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations

A C4887A polymorphism in exon 7 of human CYP1A1 : Population frequency, mutation linkages, and impact on lung cancer susceptibility

Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer

Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens

PP123—Target gene evaluation of two mirnas differently expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients

Influence of CYP3A4, CYP3A5, and ABCB1 Genotype and Expression on Budesonide Pharmacokinetics: A Possible Role of Intestinal CYP3A4 Expression

Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19

Suchergebnisse filtern